Virtu Financial’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Virtu Financial’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-188,086	Closed	-$72K	–	2527
2022 Q2	$72K	Buy	188,086 +167,733	+824%	+$117K	0.01%	1017
2022 Q1	$30K	Buy	+20,353	New	+$25.9K	﹤0.01%	1239
2021 Q4	–	Sell	-17,704	Closed	-$94K	–	2406
2021 Q3	$94K	Buy	+17,704	New	+$159K	0.01%	1163

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu Financial's CRXT Position: Q3 2022 in Review

Virtu Financial sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 188,086 shares — an estimated $72K sold.

Virtu Financial first reported a position in CRXT in Q3 2021 and held it in 3 quarters. The position peaked at $94K in Q3 2021. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

Virtu Financial reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Virtu Financial sold 188,086 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $72K.
Virtu Financial first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Virtu Financial's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $94K in Q3 2021.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.